Skip to content
Study details
Enrolling now

Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

Hospital for Special Surgery, New York
NCT IDNCT06311513ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

40

Study length

about 4.9 years

Ages

18–55

Locations

2 sites in GA, NY

What this study is about

Researchers are testing whether concentrated bone marrow aspirate (cBMA) can improve symptoms of post-traumatic osteoarthritis (PTOA) after revision anterior cruciate ligament reconstruction surgery. The trial will examine if cBMA injection leads to better pain relief, changes in inflammatory markers, and understand the cellular components that may contribute to its effects.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Concentrated Bone Marrow Aspirate Injection
  • 2.Undergo Revision Anterior Cruciate Ligament Reconstruction
  • 3.Undergo Sham Incision

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Injection / IV

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug routes

injection

Endpoints

Primary: Change from baseline in patient reported knee pain

Secondary: Change from baseline in articular cartilage relative proteoglycan content and collagen fibril organization, Change from baseline in cartilage morphology

Body systems

Musculoskeletal